Youssef Zeidan, MD, PhD, on Boosting Radiation for HER2-Positive Breast Cancer: Why It May Not Be Necessary

Posted: Wednesday, October 28, 2020

Youssef Zeidan, MD, PhD, of the American University of Beirut Medical Center, talks about his study on whether clinicians can safely forgo intensifying radiation as part of the standard regimen for patients with HER2-positive breast cancer. He also offers clinical pearls on helping patients manage treatment side effects.